** Shares of drugmaker Biogen BIIB.O rise 5.8% to $134 premarket
** Co lifts 2025 adjusted profit per share between $15.50 and $16.00, compared to prior expectations of $14.50 to $15.50
** Analysts expect 2025 profit of $14.68/share
** Co posts Q2 sales of $2.6 billion, above analysts' est of $2.32 billion - LSEG data
** Co reports Q2 profit of $5.47/share, above estimates of $3.86/share
** As of last close, stock down 17% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.